Cresud
CRESY
11.72
+0.09
+0.77%
Cresud
US · CRESY
#3395 by market cap
11.72
+0.09
+0.77%
Live - 5344 symbols - heartbeat 100s ago
· 2026-10-08 10:10
Pre-market
11.60
-0.26%
After-hours
11.63
0.00%
- Market cap
- 831.24M
- P/E (TTM)i
- 6.60
- P/Bi
- 0.87
- EPSi
- 1.78
- Div yieldi
- 5.23%
- 52W posi
- 57%
Reader sentiment
Are you bullish or bearish on CRESY?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.42, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +12.99% YoY
Margins
- Gross margin
- 39.02%
- Operating margin
- 16.97%
- Net margin
- 12.85%
Key ratios & quality
- Enterprise valuei
- 1.28T
- Altman Z-Scorei
- 0.42
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 47.53B | 82.24B | 149.93B | 767.70B | 986.27B | 1.28T | 1.22T | 1.38T |
| Gross profit | 23.98B | 35.00B | 79.39B | 340.10B | 369.17B | 542.85B | 491.53B | 538.16B |
| Selling & admin expenses | 8.42B | 11.33B | 23.00B | 95.86B | 164.18B | 172.15B | 194.92B | 202.79B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 14.59B | 18.46B | 44.80B | 180.81B | 130.67B | 288.26B | 219.99B | 234.04B |
| Pretax profit | -64.69B | 75.69B | 41.35B | 520.42B | 29.79B | 114.36B | 394.51B | 489.47B |
| Tax | 820.00M | 19.59B | 98.77B | 15.83B | -376.69B | -104.42B | 94.88B | 117.19B |
| Net profit | -61.18B | 49.27B | -86.62B | 504.59B | 406.48B | 218.78B | 299.64B | 372.28B |
| Basic EPS | -733 | 186 | -802 | 4.84K | 3.73K | 3.06K | 2.13K | 2.70K |
| Diluted EPS | -733.35 | 180.62 | -802.04 | 4,338.10 | 3,279.27 | 2,582.90 | 1,939.30 | 2,696.80 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 240.58B | 382.04B | 318.53B | 307.50B | 252.69B | 413.85B |
| Gross profit | 122.62B | 147.95B | 114.18B | 119.29B | 117.98B | 154.85B |
| Selling & admin expenses | 59.07B | 15.27B | 39.97B | 58.23B | 57.36B | 65.83B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 59.81B | 63.15B | 60.91B | 70.73B | 45.85B | 59.60B |
| Pretax profit | 203.16B | 255.53B | 190.84B | 75.63B | 14.83B | 166.61B |
| Tax | 94.23B | 33.26B | 80.71B | 484.00M | -4.24B | 25.63B |
| Net profit | 108.93B | 222.28B | 110.13B | 75.14B | 19.07B | 140.97B |
| Basic EPS | 956 | 1.63K | 588 | 555 | 628 | 797 |
| Diluted EPS | 852.10 | 1,494.00 | 588.09 | 513.70 | 627.60 | 796.90 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 218.76B | 347.00B | 114.76B | 243.58B | 1.11T | 984.87B | 1.66T | 1.82T |
| Cash & ST investments | 151.10B | 183.99B | 47.46B | 116.39B | 428.67B | 363.52B | 637.11B | 789.38B |
| Inventory | 10.20B | 17.79B | 28.73B | 48.79B | 242.99B | 243.38B | 425.73B | 420.40B |
| Total assets | 726.03B | 1.03T | 556.18B | 1.14T | 5.54T | 4.84T | 6.80T | 7.24T |
| Total current liabilities | 128.06B | 259.64B | 115.49B | 318.15B | 1.01T | 919.00B | 1.34T | 1.25T |
| Short-term debt | 80.38B | 156.28B | 77.12B | 210.31B | 562.17B | 509.55B | 758.04B | 614.82B |
| Long-term debt | 397.41B | 481.27B | 120.09B | 99.52B | 825.42B | 663.07B | 1.08T | 1.46T |
| Total liabilities | 598,833,000,000.00 | 848,309,000,000.00 | 382,537,000,000.00 | 695,110,000,000.00 | 3,037,296,000,000.00 | 2,663,976,000,000.00 | 3,839,539,000,000.00 | 4,090,132,000,000.00 |
| Total equity | 127.20B | 183.48B | 173.65B | 445.80B | 2.50T | 2.18T | 2.96T | 3.15T |
| Retained earnings | -38.91B | 3.06B | -15.82B | 45.62B | 184.26B | 83.34B | 107.87B | 158.14B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.17T | 1.66T | 1.42T | 1.59T | 1.62T | 1.82T |
| Cash & ST investments | 512.56B | 637.11B | 620.12B | 720.09B | 657.02B | 789.38B |
| Inventory | 286.62B | 425.73B | 337.72B | 393.45B | 427.46B | 420.40B |
| Total assets | 4.62T | 6.80T | 5.84T | 6.32T | 6.51T | 7.24T |
| Total current liabilities | 936.61B | 1.34T | 1.07T | 1.11T | 1.13T | 1.25T |
| Short-term debt | 528.57B | 758.04B | 544.89B | 582.80B | 545.93B | 614.82B |
| Long-term debt | 825.12B | 1.08T | 1.01T | 1.35T | 1.29T | 1.46T |
| Total liabilities | 2,719,665,000,000.00 | 3,839,539,000,000.00 | 3,313,708,000,000.00 | 3,712,294,000,000.00 | 3,692,705,000,000.00 | 4,090,132,000,000.00 |
| Total equity | 1.90T | 2.96T | 2.53T | 2.61T | 2.81T | 3.15T |
| Retained earnings | -10.65B | 107.87B | 122.44B | 58.09B | 103.76B | 158.14B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 38.37B | 88.01B | 31.42B | 174.66B | 188.03B | 152.49B | 196.76B | 62.94B |
| Depreciation & amortization | 735.00M | 4.83B | 2.95B | 9.89B | 13.92B | 19.69B | 21.68B | 23.90B |
| Free cash flow | 35.35B | 84.39B | 23.97B | 141.53B | 91.85B | 2.54B | 132.01B | 5.93B |
| Dividends paid | 0 | -2.55B | -11.66B | -66.59B | -227.19B | -230.11B | -116.76B | -105.79B |
| Stock buybacks / issuance | -1.84B | 0 | 44.67B | -213.00M | -35.64B | -24.56B | 21.98B | -28.00M |
| Ending cash balance | 134.14B | 248.58B | 97.32B | 279.62B | 201.69B | 213.44B | 335.01B | 284.47B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -28.73B | 198.55B | 151.97B | -53.63B | -52.74B | 17.35B |
| Depreciation & amortization | 6.02B | 6.80B | 4.31B | 5.43B | 6.60B | 7.57B |
| Free cash flow | -45.52B | 176.26B | 139.03B | -77.28B | -56.79B | 966.00M |
| Dividends paid | -32.21B | -8.17B | 0 | -87.20B | -9.74B | -8.86B |
| Stock buybacks / issuance | -1.91B | 42.33B | 0 | -24.00M | 24.00M | -28.00M |
| Ending cash balance | 452.41B | 335.01B | 224.75B | 434.77B | 139.92B | 284.47B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -99.35 | 18.72 | -43.64 | 64.64 | 30.05 | 17.32 | 11.54 | 14.62 |
| ROA %i | -4.35 | 0.66 | -2.45 | 8.54 | 5.49 | 3.45 | 2.25 | 2.87 |
| ROIC %i | -2.73 | 4.64 | -1.95 | 24.64 | 15.66 | 5.96 | 6.83 | 9.19 |
| 5-year avg ROE %i | -10.53 | -6.76 | -35.82 | 16.53 | 19.22 | 49.02 | 45.03 | 67.14 |
| EBIT margin %i | -12.51 | 28.26 | 59.97 | 82.47 | 14.66 | 13.08 | 40.15 | 46.83 |
| FCF / sales %i | 11.31 | 21.09 | 15.98 | 18.44 | 9.14 | -- | 11.25 | 0.43 |
| Current ratioi | 1.71 | 1.34 | 0.99 | 0.77 | 1.10 | 1.07 | 1.24 | 1.46 |
| Quick ratioi | 1.48 | 0.96 | 0.74 | 0.59 | 0.83 | 0.80 | 0.92 | 1.12 |
| Debt / assetsi | 65.81 | 64.00 | 36.80 | 28.49 | 26.72 | 25.98 | 28.76 | 30.15 |
| LT debt / equityi | 1,653.00 | 1,333.85 | 239.79 | 64.67 | 84.52 | 77.28 | 92.29 | 107.85 |
| Interest coveragei | -0.62 | 1.41 | 1.85 | 5.62 | 1.24 | 1.53 | 5.12 | 4.13 |
| Revenue CAGR (3Y) %i | 44.90 | 6.59 | 17.14 | 152.78 | 128.89 | 104.44 | 16.72 | 11.83 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | 186.99 | -- | -24.39 | -8.15 |
| FCF CAGR (3Y) %i | 115.37 | 100.56 | 14.60 | 58.78 | 2.86 | -52.70 | -2.29 | -59.88 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 9.24 | 11.54 | 18.30 | 21.24 | 17.44 | 14.62 |
| ROA %i | 1.73 | 2.25 | 3.52 | 3.81 | 3.37 | 2.87 |
| ROIC %i | 4.56 | 6.83 | 9.58 | 10.27 | 9.67 | 9.19 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 50.25 | 40.15 | 76.16 | 71.57 | 58.12 | 46.83 |
| FCF / sales %i | -- | 11.25 | 21.23 | 16.03 | 14.61 | 0.43 |
| Current ratioi | 1.25 | 1.24 | 1.33 | 1.43 | 1.43 | 1.46 |
| Quick ratioi | 0.94 | 0.92 | 1.00 | 1.06 | 1.04 | 1.12 |
| Debt / assetsi | 30.91 | 28.76 | 28.73 | 32.40 | 29.87 | 30.15 |
| LT debt / equityi | 106.46 | 92.29 | 104.36 | 132.69 | 106.95 | 107.85 |
| Interest coveragei | 8.41 | 5.12 | 8.23 | 7.80 | 4.81 | 4.13 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Agricultural Business is the largest reported line at 52.74% of revenue, across 5 reported segments.
- Business urban properties and investments follows at 38.20%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Agricultural Business52.74%
Business urban properties and investments38.20%
Settings9.70%
Region
Argentina67.85%
Brazil21.75%
Settings9.70%
Uruguay0.90%
Other countries0.44%
Quote time 2026-10-08 10:10:17 · For reference only, not investment advice and not tailored to your situation.